First patient dosing expected in Q3 2023 ZONE study to assess ZT-01’s ability to prevent night-time hypoglycemia, a condition for which there are currently no available therapies TORONTO, ON —… Read More
Five glycomics projects have been awarded funding to develop new tools, diagnostics and therapeutics to improve health for Canadians. EDMONTON, AB — GlycoNet, one of the global leaders in glycomics… Read More
Acquisition further strengthens specialty medicines and respiratory pipeline with camlipixant, a highly selective P2X3 antagonist and potential best-in-class treatment for refractory chronic cough Currently in phase III clinical development with… Read More
ZW191 demonstrates strong responses in FRα-low expressing patient-derived xenograft (PDX) models with favorable pharmacokinetic and safety profiles ZW171 induced potent preferential killing of cancer cells and potential to mitigate risk of… Read More
Routine pre-surgical use of nasal photodisinfection could prevent tens of thousands of surgical site infections a year in the US alone[i] VANCOUVER, BC — Ondine Biomedical Inc. (LON: OBI) presented… Read More
